NCT00533130Unknown不适用
Phase 2/3 Eficacy Study of the AO Pediatric Classification in Treatment and Prognosis of Long Bones Fractures
Hospital Cruz Roja Mexicana1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2007年8月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
- Is the AO Pediatric classification for long bones fractures reproductible?
- Is the AO Pediatric Classification for long bones fractures a treatment guide?
- The AO pediatric Classification for long bones fractures could be a prognosis factor?
详细描述
PROPOUSE:
- To determinate the efectivity of the AO pediatric classification for long bones fractures.
- To evaluate the functionality of the AO pediatric classification for long bones fractures.
- To analyze if the AO pediatric classification for long bones fractures is a prognosis factor
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 16 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Less than 16 years old.
- •Open physis.
- •Long bone fractures.
- •X ray AP & lateral comparatives.
- •Informed consent for parents or tutor.
- •Don´t let the treatment during the time of study.
排除标准
- •Pathologic fractures.
- •Fractures not included en the AO pediatric classification for long bones.
- •Diseases that modifying the bone healing: Diabetes mellitus, osteogenesis imperfect, etc.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2)Hepatitis C, ChronicNCT00761735Merck Sharp & Dohme LLC94
招募中
不适用
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid TumorsRare Unresectable or Metastatic BRAF V600E Mutation-positive Solid TumorsNCT05868629Novartis Pharmaceuticals40
已完成
3 期
Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in ChinaHaemophilus Influenzae Type b (Hib) InfectionNCT01025544Novartis Vaccines846
已完成
2 期
Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard ChemotherapyColorectal CancerNCT01378143Oncozyme Pharma Inc.53
已完成
不适用
Trilogy Comparison Study - PediatricsRespiratory FailureNCT00810459Philips Respironics6